"Paths of Glory" hasn't lost an ounce of its staying power in the 69 years since its theatrical release. It's a sharp, ...
Full-year 2025 net product revenues of $689 million SYFOVRE® (pegcetacoplan injection) full year 2025 net product revenue of $587 millionEMPAVELI® (pegcetacoplan) full year 2025 net product revenue of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results